2/12/2020
On February 12, 2020, the United States Food and Drug Administration (FDA) published a notice regarding a Class I recall of MiniMed 600 Series Insulin Pumps manufactured by Medtronic. This recall was issued due to a missing or broken retainer ring which helps to lock the insulin cartridge into place in the pump's reservoir compartment. If the cartridge is not locked firmly into place, under or over delivery of insulin may occur, which could result in hypoglycemia or hyperglycemia. Severe hyperglycemia can result in a loss of consciousness, seizure, and death.
This recall affects
People who have Type 1 diabetes may use the MiniMed insulin pump to deliver insulin for the management of their diabetes.
The Model 630G insulin pump may be used by persons sixteen years of age and older.
The Model 670G insulin pump may be used by persons fourteen years of age and older.
Medtronic has received a total of 26,421 complaints in which the device malfunctioned in this manner. Medtronic is aware of 2,175 injuries and 1 death.
Medtronic notified affected patients and advised them to:
CVS Caremark Response: Because of this action, CVS Caremark® is sending letters to members who received this product through CVS Caremark® Mail Service Pharmacy and their physicians
For more information, please contact Medtronic Technical Support at 1-877-585-0166 or visit www.medtronicdiabetes.com/PumpRing. You may also contact the FDA consumer inquiry line toll-free at 1‑888‑INFO-FDA (1‑888-463-6332) or visit www.fda.gov.
Copyright © 2025 CVS Caremark. All rights reserved| Terms and Conditions | Privacy Policy | Accessibility | Member Rights & Responsibilities | Vulnerability Disclosure Program